Anhui Anke Biotechnology (Group) Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100000GY2
CNY
8.86
0.07 (0.8%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
541.72
683.93
670.40
663.43
628.75
614.76
622.47
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
541.72
683.93
670.40
663.43
628.75
614.76
622.47
Raw Material Cost
132.23
182.83
178.46
170.05
155.49
156.51
155.79
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.11
0.26
0.51
0.59
0.57
0.32
0.64
Selling and Distribution Expenses
180.02
239.65
230.69
253.87
203.66
294.44
219.12
Other Expenses
3.59
7.04
4.57
5.82
3.02
7.00
4.41
Total Expenditure (Excl Depreciation)
348.29
493.14
455.32
482.70
389.94
521.24
419.66
Operating Profit (PBDIT) excl Other Income
193.4
190.79999999999998
215.10000000000002
180.7
238.79999999999998
93.5
202.8
Other Income
9.60
12.11
17.33
15.21
20.35
22.11
17.31
Operating Profit (PBDIT)
197.92
214.63
258.52
218.94
285.09
134.78
246.86
Interest
0.11
0.26
0.51
0.59
0.57
0.32
0.64
Exceptional Items
4.16
0.11
2.76
-0.01
-0.98
13.08
-3.78
Gross Profit (PBDT)
409.49
501.10
491.94
493.39
473.26
458.25
466.67
Depreciation
0.00
31.99
31.99
31.42
31.42
31.70
31.70
Profit Before Tax
201.97
182.49
228.78
186.92
252.12
115.85
210.74
Tax
24.97
-0.24
28.54
22.98
34.55
-11.18
30.11
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
167.59
183.71
184.97
157.51
209.00
117.23
173.59
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
167.59
183.71
184.97
157.51
209.00
117.23
173.59
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
4.58
1.01
3.10
3.72
4.31
-1.31
2.56
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
172.16
184.72
188.07
161.24
213.31
115.92
176.14
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
4,743.45
4,558.02
4,168.91
3,970.43
4,085.10
4,124.31
3,937.69
Earnings per share (EPS)
0.1
0.11
0.11
0.1
0.13
0.07
0.11
Diluted Earnings per share
0.1
0.11
0.11
0.1
0.13
0.07
0.11
Operating Profit Margin (Excl OI)
34.76%
24.93%
31.21%
25.97%
37.11%
13.17%
31.78%
Gross Profit Margin
37.28%
31.36%
38.9%
32.91%
45.1%
24.0%
38.95%
PAT Margin
30.94%
26.86%
27.59%
23.74%
33.24%
19.07%
27.89%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Mar 2026 is -20.79% vs 2.01% in Dec 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Mar 2026 is -6.77% vs -1.81% in Dec 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Mar 2026 is -7.01% vs -16.04% in Dec 2025

stock-summary

Interest

QoQ Growth in quarter ended Mar 2026 is -66.67% vs -40.00% in Dec 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

Compare Quarterly Results Of Anhui Anke Biotechnology (Group) Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
541.72
0
541.72
Other Operating Income
0.00
0.00
0.00
Total Operating income
541.72
0
541.72
Raw Material Cost
132.23
0
132.23
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.11
0
0.11
Selling and Distribution Expenses
180.02
0
180.02
Other Expenses
3.59
0.00
3.59
Total Expenditure (Excl Depreciation)
348.29
0
348.29
Operating Profit (PBDIT) excl Other Income
193.42
0.00
193.42
Other Income
9.60
0
9.60
Operating Profit (PBDIT)
197.92
0
197.92
Interest
0.11
0
0.11
Exceptional Items
4.16
0
4.16
Gross Profit (PBDT)
409.49
0
409.49
Depreciation
0.00
0
0.00
Profit Before Tax
201.97
0
201.97
Tax
24.97
0
24.97
Provisions and contingencies
0
0
0.00
Profit After Tax
167.59
0
167.59
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
167.59
0
167.59
Share in Profit of Associates
0
0
0.00
Minority Interest
4.58
0
4.58
Other related items
0.00
0.00
0.00
Consolidated Net Profit
172.16
0
172.16
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
4,743.45
0
4,743.45
Earnings per share (EPS)
0.10
0
0.10
Diluted Earnings per share
0.10
0
0.10
Operating Profit Margin (Excl OI)
34.76%
0%
0.00
34.76%
Gross Profit Margin
37.28%
0%
0.00
37.28%
PAT Margin
30.94%
0%
0.00
30.94%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 54.17 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -20.79% vs 2.01% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -13.85% vs -3.34% in Mar 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 17.22 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -6.77% vs -1.81% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -19.27% vs -3.88% in Mar 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 18.83 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -7.01% vs -16.04% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -28.86% vs -3.53% in Mar 2025

Quarterly - Interest
Interest 0.01 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -66.67% vs -40.00% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -83.33% vs -33.33% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 34.76%
in Mar 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025